Comparing the Effectiveness of IV Bezlotoxumab Versus Placebo in Decreasing Morbidity and Mortality in Patients With Fulminant C. Diff Requiring Surgery.

计划入组 5 人 · 首次发布于 2018 年 11 月 28 日

Multicentre Blinded Comparison of Lyophilized Sterile Fecal Filtrate to Lyophilized Fecal Microbiota Transplant in Recurrent Clostridioides Difficile Infection

计划入组 138 人 · 首次发布于 2019 年 1 月 16 日

Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)

计划入组 260 人 · 首次发布于 2020 年 3 月 12 日

clostridium ghonii

Clostridium botulinum

Clostridium tetani

Gut Microbiome Changes Can Signal Future Type 2 Diabetes Risk Years Before Diagnosis, Large Swedish Study Finds

Phase 3b Trial Shows Colonoscopic Administration of Rebyota Effective for Preventing Recurrent C. difficile Infection

Ibezapolstat Shows Promise in Phase 2 Trial for Clostridioides difficile Infection